Agios Pharmaceuticals (AGIO)'s 30-day implied volatility (IV30) was 51.7% at the close on November 16, 2026, up from 45.9% the day before, against a 52-week range of 40.5% to 237.0%. Its 20-day historical volatility was 64.0%.
Data as of November 16, 2026.